Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids

References

• IDPH. Illinois Department of Public Health. 2018. Available from: http://www.dph.illinois.gov/search/site/synthetic%20cannabinoids
   Google Scholar
• Feinstein DL, Akpa BS, Ayee MA, et al. The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures. Ann NY Acad Sci. 2016;1374(1):111–122.
   PubMed Web of Science ®Google Scholar
• Kelkar AH, Smith NA, Martial A, et al. An outbreak of synthetic cannabinoid-associated coagulopathy in Illinois. N Engl J Med. 2018;379(13):1216–1223.
   PubMed Web of Science ®Google Scholar
• Navon L, Moritz E, Austin C, et al. The public health response to a large poisoning outbreak involving an illicit substance: synthetic cannabinoids contaminated with a long-acting anticoagulant rodenticide, Illinois, March–July. J Public Health Manag Pract. 2019. [Epub ahead of print]. doi:10.1097/PHH.0000000000001002.
   PubMed Web of Science ®Google Scholar
• Moritz E, Austin C, Wahl M, et al. Notes from the field: outbreak of severe illness linked to the vitamin k antagonist brodifacoum and use of synthetic cannabinoids – Illinois, March–April 2018. MMWR Morb Mortal Wkly Rep. 2018;67(21):607–608.
   PubMed Web of Science ®Google Scholar
• Tole M, LaBedz S, Feinstein DL, et al. Adherence to long-term follow-up of patients with life-threatening, inhaled synthetic cannabinoids-associated coagulopathy in Chicago. Lung. 2019;197(3):349.
   PubMed Web of Science ®Google Scholar
• Rubinstein I, Weinberg G, van Breemen R, et al. Treatment for long acting anticoagulant rodenticide poisoning – beyond INR monitoring? Toxicol Comm. 2018;2(1):59–61.
   PubMedGoogle Scholar
• Feinstein DL, Gierzal K, Iqbal A, et al. The relative toxicity of brodifacoum enantiomers. Toxicol Lett. 2019;306:61–65.
   PubMed Web of Science ®Google Scholar
• Hauck ZZ, Feinstein DL, van Breemen RB. LC-MS-MS analysis of brodifacoum isomers in rat tissue. J Anal Toxicol. 2016;40(4):304–309.
   PubMed Web of Science ®Google Scholar
• Damin-Pernik M, Espana B, Lefebvre S, et al. Management of rodent populations by anticoagulant rodenticides: toward third-generation anticoagulant rodenticides. Drug Metab Dispos. 2017;45(2):160–165.
   PubMed Web of Science ®Google Scholar
• Lefebvre S, Hascoet C, Damin-Pernik M, et al. Monitoring of antivitamin K-dependent anticoagulation in rodents – towards an evolution of the methodology to detect resistance in rodents. Pestic Biochem Physiol. 2017;138:29–36.
   PubMed Web of Science ®Google Scholar
• Hauck Z. Tissue distribution, pharmacokinetics and metabolism of brodifacoum: a superwarfarin [dissertation]. Chicago (IL): University of Illinois at Chicago; 2017.
   Google Scholar
• Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257–3291.
   PubMed Web of Science ®Google Scholar
• Holbrook A, Schulman S, Witt DM, et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2):e152S–ee84S.
   PubMed Web of Science ®Google Scholar
• Khatib R, Ludwikowska M, Witt DM, et al. Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis. Blood Adv. 2019;3(5):789–796.
   PubMed Web of Science ®Google Scholar
• Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236–239.
   PubMed Web of Science ®Google Scholar
• Lindeblad M, Lyubimov A, van Breemen R, et al. The bile sequestrant cholestyramine increases survival in a rabbit model of brodifacoum poisoning. Toxicol Sci. 2018;165(2):389–395.
   PubMed Web of Science ®Google Scholar
• Yaqoob M, Feinstein DL, Rubinstein I. Pregnancy in women with life-threatening poisoning with long-acting anticoagulant rodenticides. Mayo Clin Proc. 2019;94:1646–1647.
   PubMed Web of Science ®Google Scholar
• Wang M, Yang Y, Hou Y, et al. Effects of bromadiolone poisoning on the central nervous system. Neuropsychiatr Dis Treat. 2017;13:2297–2300.
   PubMed Web of Science ®Google Scholar
• Kalinin S, Marangoni N, Kowal K, et al. The long-lasting rodenticide brodifacoum induces neuropathology in adult male rats. Toxicol Sci. 2017;159(1):224–237.
   PubMed Web of Science ®Google Scholar
• Ware KM, Feinstein DL, Rubinstein I, et al. Brodifacoum induces early hemoglobinuria and late hematuria in rats: novel rapid biomarkers of poisoning. Am J Nephrol. 2015;41(4–5):392–399.
   PubMed Web of Science ®Google Scholar
• Marangoni MN, Martynowycz MW, Kuzmenko I, et al. Membrane cholesterol modulates superwarfarin toxicity. Biophys J. 2016;110(8):1777–1788.
   PubMed Web of Science ®Google Scholar
• van Heerden PS, Bezuidenhoudt BCB, Ferreira D. Improved synthesis for the rodenticides, diphenacoum and brodifacoum J Chem Soc Perkin Trans. 1997;1(8):1141–1146.
   Google Scholar
• Jung JC, Oh S. Practical synthesis of hydroxychromenes and evaluation of their biological activity. Molecules. 2011;17(1):240–247.
   PubMed Web of Science ®Google Scholar
• King N, Tran MH. Long-acting anticoagulant rodenticide (superwarfarin) poisoning: a review of its historical development, epidemiology, and clinical management. Transfus Med Rev. 2015;29(4):250–258.
   PubMed Web of Science ®Google Scholar
• Gunja N, Coggins A, Bidny S. Management of intentional superwarfarin poisoning with long-term vitamin K and brodifacoum levels. Clin Toxicol. 2011;49(5):385–390.
   Web of Science ®Google Scholar
• Vandenbroucke V, Bousquet-Melou A, De BP, et al. Pharmacokinetics of eight anticoagulant rodenticides in mice after single oral administration. J Vet Pharmacol Ther. 2008;31(5):437–445.
   PubMed Web of Science ®Google Scholar
• Sconce E, Avery P, Wynne H, et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007;109(6):2419–2423.
   PubMed Web of Science ®Google Scholar
• Kim JS, Nafziger AN, Gaedigk A, et al. Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probe. J Clin Pharmacol. 2001;41(7):715–722.
   PubMed Web of Science ®Google Scholar
• Schaefer N, Kroll AK, Korbel C, et al. Distribution of the (synthetic) cannabinoids JWH-210, RCS-4, as well as 9-tetrahydrocannabinol following pulmonary administration to pigs. Arch Toxicol. 2019;93(8):2211.
   PubMed Web of Science ®Google Scholar
• Renowden S, Westmoreland D, White JP, et al. Oral cholestyramine increases elimination of warfarin after overdose. Br Med J. 1985;291(6494):513–514.
   PubMed Web of Science ®Google Scholar